2020
DOI: 10.1016/s0016-5085(20)31571-7
|View full text |Cite
|
Sign up to set email alerts
|

Sa1560 PROTEIN TRUNCATING SPLICE VARIANT (RS72613567) IN HSD17B13 GENE DOES NOT CONFER PROTECTION TO NAFLD IN INDIAN POPULATION

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Previously, a large study reported that loss-of-function variant in HSD17B13 was associated with a reduced risk of chronic liver disease and progression from steatosis to steatohepatitis. However, when the same was tested across the Indian population, no protection was offered in the subset of patients carrying the same splice variant (5). In conclusion, the current study is unique and, for the first time, highlights the importance of genetic factors and the presence of diabetes as the most important predictor of the development of cirrhosis due to alcohol misuse.…”
Section: Commentsmentioning
confidence: 86%
See 1 more Smart Citation
“…Previously, a large study reported that loss-of-function variant in HSD17B13 was associated with a reduced risk of chronic liver disease and progression from steatosis to steatohepatitis. However, when the same was tested across the Indian population, no protection was offered in the subset of patients carrying the same splice variant (5). In conclusion, the current study is unique and, for the first time, highlights the importance of genetic factors and the presence of diabetes as the most important predictor of the development of cirrhosis due to alcohol misuse.…”
Section: Commentsmentioning
confidence: 86%
“…In the last decade, the historic STOPAH trial and subsequent meta-analysis have validated the use of corticosteroids in reducing 28-day mortality in sAH. 4,5 However, a…”
Section: Commentsmentioning
confidence: 99%
“…10 Apart from the approach (GWAS and whole exome sequencing), the other compounding issue in identifying reliable genetic variants to complex disease is ethnic variation predominantly because of the lack of representation of varied ethnic samples in large GWAS. 11 Studies from our lab have shown that the protein truncating splice variant (rs72613567:TA) in HSD17B13 gene does not confer protection against NAFLD 12 and the risk variant (rs738409) in PNPLA3 gene is not associated with metabolic syndrome, 13 suggesting the role of other genetic loci. There are limited studies reported from the Indian ethnicity that evaluated genetic susceptibility for NAFLD at a global genome-wide level.…”
Section: Introductionmentioning
confidence: 99%